Curious cases of financial engineering in biotech

The article examines instances of financial engineering in the biotechnology sector, exploring how companies use complex financial strategies to manage risks, raise capital, and influence stock performance. It highlights specific cases where such tactics have impacted company valuations and investor outcomes.